Cargando…
Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis
OBJECTIVES: To perform a systematic review and network meta‐analysis to compare the efficacy and safety of currently available treatments for the management of metastatic hormone‐sensitive prostate cancer (mHSPC), as there has been a paradigm shift with the use of next‐generation androgen receptor i...
Autores principales: | Mori, Keiichiro, Mostafaei, Hadi, Sari Motlagh, Reza, Pradere, Benjamin, Quhal, Fahad, Laukhtina, Ekaterina, Schuettfort, Victor M., Kramer, Gero, Abufaraj, Mohammad, Karakiewicz, Pierre I., Kimura, Takahiro, Egawa, Shin, Shariat, Shahrokh F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291853/ https://www.ncbi.nlm.nih.gov/pubmed/34171173 http://dx.doi.org/10.1111/bju.15507 |
Ejemplares similares
-
Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020) -
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021) -
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020) -
Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review
por: Aydh, Abdulmajeed, et al.
Publicado: (2020) -
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)